Ovarian Cancer and Peripheral Neuropathy Pam Shlemon, former FPN Executive Director, joined Amanda Davis of the Ovarian Cancer National Alliance on a moderated webinar discussing the connection between ovarian cancer and PN.
From Our Blog...
Chemotherapy-Induced Peripheral Neuropathy Common, but Underdiagnosed
Dr. Noah Kolb, MD of the University of Utah (a consortium partner of the Foundation’s for Peripheral Neuropathy Research Registry) presented results at the recent
Nerve Pain Therapy: Botox May Treat Peripheral Neuropathy in Cancer Patients
Neuropathy is a common side effect of certain medications, especially those used in chemotherapy to fight cancer like cisplatin, carboplatin, and oxaliplatin. While symptoms might
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Chemotherapy-induced peripheral neuropathy (CIPN) is a common treatment-related adverse effect and affects long-term quality of life.1 It has the potential to result in chemotherapy dose
Rodent Models of Chemotherapy-Induced Peripheral Neuropathy
A common complication of chemotherapy is neurotoxicity that often manifests itself as peripheral neuropathy. Many cancer drugs can cause chemotherapy-induced peripheral neuropathy (CIPN), and the
Ethoxyquin Prevents Chemotherapy-Induced Neurotoxicity via Hsp90 Modulation
A team of researchers has just published their results of a study to determine if there was a way to prevent peripheral neuropathy from pacitaxel,
Nutraceuticals and Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Systematic Review
A team of researchers at Queensland, School of Medicine, reviewed 24 studies to determine if nutraceuticals (i.e., vitamin E, acetyl-L-carnitine, glutamine, glutathione, alpha lipoic acid,